Biogen
Biogen pioneers innovative science to deliver transformative medicines for neurology, immunology, and rare diseases.
Biogen is a global biotechnology company dedicated to pioneering innovative science to treat complex and devastating diseases. Based in Cambridge, Massachusetts, the company focuses on developing and delivering transformative therapies for patients with serious unmet medical needs, particularly in the fields of neurology, immunology, and rare diseases. Its work spans from early-stage drug discovery to large-scale pharmaceutical manufacturing.
The company applies a deep understanding of human biology and leverages various modalities, including small molecules, biologics, and antisense oligonucleotides (ASOs), to advance first-in-class treatments. Biogen's therapeutic focus areas include Alzheimer's disease, multiple sclerosis, spinal muscular atrophy, Friedreich ataxia, and lupus.
With a legacy dating back to 1978, Biogen operates a global network of affiliates and distribution partners serving patients in over 80 countries. The company is characterized by its willingness to take bold scientific risks to achieve breakthroughs that can significantly improve patient outcomes and create long-term value for shareholders and communities.
- Headquarters
- Cambridge, MA, United States
- Founded
- 1978
- Website: biogen.com
Industries: Biotechnology, Pharmaceuticals
Categories: Drug Discovery, Clinical Trials
AntSpace put this profile together from public information. It may be incomplete; once Biogen claims it, its admins can edit everything here.
Our vision
Biogen's vision is to transform rigorous science into first-in-class medicines and create new possibilities through scientific curiosity and aspirations to help people around the world.
Our culture
Biogen's culture is defined by a spirit of ethics, inclusivity, agility, and an unwavering focus on patients. The company operates under "The Biogen Way," which emphasizes five culture essentials: Pioneer, Think Broadly, Drive Results, Ethical, and Inclusive. Employees are encouraged to take bold risks balanced with a return on investment to deliver long-term growth. The organization fosters an environment of curiosity and humility, integrating both internal and external advances to remain competitive. Biogen is committed to building a safe, inclusive environment where diverse perspectives are welcomed and leveraged to solve complex systemic issues in the biotechnology field.
Core values
- Pioneer
- Think Broadly
- Drive Results
- Ethical
- Inclusive
Specialties
- Autoimmune diseases
- Rare genetic diseases
- Clinical development
Markets served
- Biotechnology
- Pharmaceuticals
- Neurology
- Immunology
- Rare Diseases
- Nephrology
Key facts
- Legal name
- Biogen Inc.
- Countries
- 80
Latest from Biogen
- New Five-Year Lecanemab Data from Clarity AD Study Long-Term Extension Presented at CTAD 2026 (Achievement · November 16, 2026)
Biogen shared five-year data from the Clarity AD study long-term extension, showing the long-term effects of lecanemab in patients. The results were presented at the Clinical Trials on Alzheimer’s…
Products by Biogen
- Biogen Early Access Programs
Providing pathways to investigational medicines for patients with serious unmet medical needs.
Services by Biogen
- Biogen Strategic Partnerships (Consulting & advisory)
Transforming breakthrough science into global commercial success through strategic collaboration.
Clients and partners
4 clients and partners
Case studies
4 case studies
Documents
2 documents
Locations
- Headquarters · Cambridge, United States (headquarters)
5 more products, services and AI on AntSpace. Sign up free to see the full catalog.
Leadership, clients, case studies, documents and every location on AntSpace. Sign up free to see them.